201 related articles for article (PubMed ID: 32266066)
1. Metabolic regulation of calcium pumps in pancreatic cancer: role of phosphofructokinase-fructose-bisphosphatase-3 (PFKFB3).
Richardson DA; Sritangos P; James AD; Sultan A; Bruce JIE
Cancer Metab; 2020; 8():2. PubMed ID: 32266066
[TBL] [Abstract][Full Text] [Related]
2. Cutting off the fuel supply to calcium pumps in pancreatic cancer cells: role of pyruvate kinase-M2 (PKM2).
James AD; Richardson DA; Oh IW; Sritangos P; Attard T; Barrett L; Bruce JIE
Br J Cancer; 2020 Jan; 122(2):266-278. PubMed ID: 31819190
[TBL] [Abstract][Full Text] [Related]
3. The Plasma Membrane Calcium Pump in Pancreatic Cancer Cells Exhibiting the Warburg Effect Relies on Glycolytic ATP.
James AD; Patel W; Butt Z; Adiamah M; Dakhel R; Latif A; Uggenti C; Swanton E; Imamura H; Siriwardena AK; Bruce JI
J Biol Chem; 2015 Oct; 290(41):24760-71. PubMed ID: 26294767
[TBL] [Abstract][Full Text] [Related]
4. Glycolytic ATP fuels the plasma membrane calcium pump critical for pancreatic cancer cell survival.
James AD; Chan A; Erice O; Siriwardena AK; Bruce JI
J Biol Chem; 2013 Dec; 288(50):36007-19. PubMed ID: 24158437
[TBL] [Abstract][Full Text] [Related]
5. Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma.
Yang K; Qiu T; Zhou J; Gong X; Zhang X; Lan Y; Zhang Z; Ji Y
J Transl Med; 2023 Feb; 21(1):85. PubMed ID: 36740704
[TBL] [Abstract][Full Text] [Related]
6. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
[TBL] [Abstract][Full Text] [Related]
7. Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma.
Li HM; Yang JG; Liu ZJ; Wang WM; Yu ZL; Ren JG; Chen G; Zhang W; Jia J
J Exp Clin Cancer Res; 2017 Jan; 36(1):7. PubMed ID: 28061878
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous inhibition of PFKFB3 and GLS1 selectively kills KRAS-transformed pancreatic cells.
Ozcan SC; Mutlu A; Altunok TH; Gurpinar Y; Sarioglu A; Guler S; Muchut RJ; Iglesias AA; Celikler S; Campbell PM; Yalcin A
Biochem Biophys Res Commun; 2021 Sep; 571():118-124. PubMed ID: 34325126
[TBL] [Abstract][Full Text] [Related]
9. p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Wang F; Qi XM; Wertz R; Mortensen M; Hagen C; Evans J; Sheinin Y; James M; Liu P; Tsai S; Thomas J; Mackinnon A; Dwinell M; Myers CR; Bartrons Bach R; Fu L; Chen G
Cancer Res; 2020 Aug; 80(16):3251-3264. PubMed ID: 32580961
[TBL] [Abstract][Full Text] [Related]
10. 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase-3 is required for transforming growth factor β1-enhanced invasion of Panc1 cells in vitro.
Yalcin A; Solakoglu TH; Ozcan SC; Guzel S; Peker S; Celikler S; Balaban BD; Sevinc E; Gurpinar Y; Chesney JA
Biochem Biophys Res Commun; 2017 Mar; 484(3):687-693. PubMed ID: 28161638
[TBL] [Abstract][Full Text] [Related]
11. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
[TBL] [Abstract][Full Text] [Related]
12. Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 gene (PFKFB3, iPFK2).
Mahlknecht U; Chesney J; Hoelzer D; Bucala R
Int J Oncol; 2003 Oct; 23(4):883-91. PubMed ID: 12963966
[TBL] [Abstract][Full Text] [Related]
13. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
15. Plasma Membrane Ca
Sritangos P; Pena Alarcon E; James AD; Sultan A; Richardson DA; Bruce JIE
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31963119
[TBL] [Abstract][Full Text] [Related]
16. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
Jones BC; Pohlmann PR; Clarke R; Sengupta S
Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
[TBL] [Abstract][Full Text] [Related]
17. Increased 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 activity in response to EGFR signaling contributes to non-small cell lung cancer cell survival.
Lypova N; Telang S; Chesney J; Imbert-Fernandez Y
J Biol Chem; 2019 Jul; 294(27):10530-10543. PubMed ID: 31126985
[TBL] [Abstract][Full Text] [Related]
18. [Effect of Hematopoietic Pre-B-cell Leukemia Transcription Factor Interacting Protein Knockdown on Proliferation,Cell Cycle and Apoptosis in Pancreatic Cancer Cells].
Zhao YM; Yang G; You L; Hu Y; Zhao YP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):7-15. PubMed ID: 32131934
[No Abstract] [Full Text] [Related]
19. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.
Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H
Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846
[TBL] [Abstract][Full Text] [Related]
20. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
